Claims for Patent: 8,357,713
✉ Email this page to a colleague
Summary for Patent: 8,357,713
| Title: | Compounds and compositions and methods of use |
| Abstract: | Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid. |
| Inventor(s): | Barry D. Quart, Jean-Luc Girardet, Esmir Gunic, Li-Tain Yeh |
| Assignee: | Ardea Biociences Inc |
| Application Number: | US13/174,568 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,357,713 |
| Patent Claims: |
1. A pharmaceutical composition comprising a compound of formula (IV): or a pharmaceutically acceptable salt, ester, or tautomer thereof. 2. A method of reducing serum uric acid levels in a human, the method comprising administering to the human a composition of claim 1. 3. A method of treating gout in a human, the method comprising administering to the human a composition of claim 1. 4. A method of treating hyperuricemia in a human, the method comprising administering to the human a composition of claim 1. 5. The pharmaceutical composition of claim 1, further comprising a second agent effective for treatment of gout. 6. The pharmaceutical composition of claim 5, wherein the second agent is a URAT 1 inhibitor, a xanthine oxidase inhibitor, a xanthine dehydrogenase, a xanthine oxidoreductase inhibitor, or a combination thereof. 7. The pharmaceutical composition of claim 5, wherein the second agent is allopurinol. 8. The pharmaceutical composition of claim 5, wherein the second agent is febuxostat. 9. The pharmaceutical composition of claim 1, further comprising a pharmaceutically acceptable carrier, diluent, or binder. 10. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a tablet or capsule. 11. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a tablet. 12. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a coated tablet. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
